Hepatitis B immune globulin - SK ChemicalsAlternative Names: HBIG; Hepabulin Antibody injection; Hepabulin IV; IV Hepabulin SN
Latest Information Update: 20 Apr 2016
At a glance
- Originator SK Chemicals
- Developer SK Chemicals; SK Plasma
- Class Antivirals; Immunoglobulins
- Mechanism of Action Immunostimulants
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity No
Highest Development Phases
- Marketed Hepatitis B